> SERIES A CLOSED. 6 MCHF INVESTED IN TOTAL IN PB&B TO DATE

> SERIES B OPENED, DO NOT HESITATE TO CONTACT US IF YOU WISH TO RECEIVE MORE INFORMATION AND WOULD LIKE TO BE PART OF THE NEXT REVOLUTION IN AESTHETICS

 

If you have question first look at the FAQ or send us a message using the contact form.

INVESTMENT CASE

 

  • – PB&B owns 100% of its IP; no royalty nor equity stakes taken by academic partners or third parties on PB&B’s IP
  • – Recession proof global market with double digit growth
  • – Platform technology with applications in facial aging & body remodeling with a strong IP position – Medical Aesthetics is a field with the least new technology companies & innovations
  • – Novel medical Aesthetic technology typically acquired in the billion dollar range
  • – PB&B considered by Plastic Surgeons at the technology the replacement to autologous fat transfer procedures
  • – PB&B gained the financial & logistical support of the Swiss federal & local state government economic promotion office for scientific innovation. PB&B has won multiple national & international prizes & nominations for its scientific innovations worldwide.

 

Contact us now

plant growing